Clinical trial

A Study Looking at Novel Scheduling of Cabazitaxel for Patients With Metastatic Prostate Cancer

NCT01541007

Study summary

ClinicalTrials.gov

A Study Looking at Novel Scheduling of Cabazitaxel for Patients With Metastatic Prostate Cancer

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Mapped RxNorm record Cabazitaxel Normalized identity: cabazitaxel View linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention weekly cabazitaxel Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2012-04-01

PhasePHASE2

Conditions

Metastatic Castration Resistant Prostate Cancerunresolved

Interventions

CabazitaxelDRUG · verified · RxNorm: cabazitaxel

weekly cabazitaxelDRUG

Sponsors & collaborators

Jeffrey Yachnin M.D., PhD.lead sponsor

Sanoficollaborator

Mapped research locations

StockholmSweden1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01541007 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.